This report was recently updated on April 18 2024 with the latest and most recent
market numbers
Global Leukapheresis Market Size, Trends & Analysis - Forecasts To 2026 By Product (Leukapheresis Devices, Platelet Lysate with Heparin), By Application (Therapeutic Applications, Research Applications), By End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical And Biotechnology, Hospitals And Transfusion Centers), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis
Leukapheresis Market: Insights
The global leukapheresis market is expected to generate revenue amounting to USD 22.49 million in 2020, and is projected to reach to USD 34.40 million by 2026, growing at a CAGR of 7.34% over the forecast period. Increasing incidence and prevalence of leukemia is one of the major factor expected to propel the market growth for leukapheresis during the forecast period. According to NIH estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the last 10 years. They also estimated that in 2018 approximately 60,300 cases were registered. According to the Leukemia & Lymphoma Society, leukemia was the sixth-most-common cause of cancer deaths globally. Increasing number of blood donations across the globe is also driving the market for leukapheresis.
Rising demand for leukopaks in the development of cell-based therapies is expected to drive the market growth for leukapheresis during the forecast period. Growing incidence of leukemia cancer across various regions including North America, Europe, Asia Pacific, and Central & South America is further projected to propel the market growth of Leukapheresis. The rising number of trauma cases and growing policies on reimbursements and increasing number of complex surgeries are anticipated to boost the market growth during the forecast period. However, high cost involved in leukapheresis procedures and lack of qualified doctors, are likely to hamper the market growth during the forecast period.
Leukapheresis Market Size: By Segmentation
The global Leukapheresis market is segmented on the basis of product type into leukapheresis devices, and leukapheresis disposables. The leukapheresis devices segment is further segmented into apheresis devices, leukapheresis columns and cell separators, leukoreduction filters. The leukapheresis disposables segment is expected to hold the largest market share in the global Leukapheresis market during the forecast period. Growing demand for leukopaks are driving the market growth for devices segment. Rising applications of leukapheresis procedures for the isolation of white blood cells (WBCs) or leukocytes or leucocytes and repeated consumption of disposables in leukapheresis procedures is estimated to drive the market growth during the forecast period.
On the basis of end user, the global leukapheresis market is segmented into blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies, hospitals and transfusion centers. The blood component providers and blood centers segment is expected to hold the largest market share during the forecast period. Growing demand for blood and blood components are driving the market growth for blood centers segment. Approximately 21 million units of blood components are transfused every year in the US. Approximately 44,000 units of blood are required every day in the U.S. for emergency treatment facilities.
Leukapheresis Market Size: By Region
On the basis of region, the market of leukapheresis is segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. The North America region is expected to hold the largest market share in the global leukapheresis market during the forecast period. Rise in geriatric population, and increasing prevalence and incidence of leukemia is driving the market growth in the region. According to data published by Leukemia and Lymphoma Society (LLS), in 2019 approximately 61,780 people were expected to be diagnosed with leukemia in the region. Increasing clinical research activities and larger presence of biotech and pharma companies is propelling the market growth in the region. Presence of key players such as Haemonetics, Terumo BCT, STEMCELL Technologies, Key Biologics, and BioIVT are also driving the market growth in the region.
Please note: This is not an exhaustive list of companies profiled in the report.
Leukapheresis Market Landscape
Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis for separating out one particular constituent of blood and returning the remainder to the circulation. Leukapheresis may be performed to obtain the patient's own blood cells for later transplant.
In January 2020, Fresenius inaugurated EUR 30 million expansion of transfusion and apheresis disposables plant in Dominican Republic.
In July 2017, Haemonetics Corporation received FDA clearance for its NexSys PCS plasmapheresis system. The NexSys PCS includes bi-directional connectivity to Haemonetics' donor management system.
Check the Press Release on Global Leukapheresis Market Report
Leukapheresis Market: By Product
Leukapheresis Market: By Application
Leukapheresis Market: By End User
Leukapheresis Market: By Region
The global Leukapheresis Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Leukapheresis Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
